Cite
MLA Citation
Sayeh M. Lavasani et al.. “Phase 2 prospective open label study of neoadjuvant nab‐paclitaxel, trastuzumab, and pertuzumab in patients with HER2‐positive primary breast cancer.” Cancer, vol. 129, no. 5, 2023, pp. 740–749. http://access.bl.uk/ark:/81055/vdc_100177549451.0x000062